Logo
Lipo Lab V Line

Lipo Lab V Line

Lipo Lab

Fat Dissolver
  • Manufactured in South Korea by Medi Hub for aesthetic medical use.
  • Marketed internationally as a professional Use injectable facial fat dissolving solution.
  • Described by distributors as clinically approved by the Korean Ministry of Food and Drug Safety (KFDA/MFDS) for fat reduction indications.
Facial Fat Dissolving Injection

Description

Lipo Lab V-Line is an injectable facial fat-dissolving solution formulated to contour and slim the lower face. Using phosphatidylcholine, sodium deoxycholate, and a complex of plant extracts, vitamins and amino acids, it targets localised fat in areas such as the jawline, double chin and cheeks to create a more defined V-shaped facial profile with lifting and tightening benefits.

Bnefits

  • Targets localised fat deposits in the jawline, chin, cheeks and neckline to refine the V-line facial contour.
  • Destroys fat cells rather than simply shrinking them, supporting longer-lasting contouring results when lifestyle is maintained.
  • Supports skin tightening and elasticity for a smoother, more lifted appearance.
  • Promotes cell regeneration and skin rejuvenation, leaving skin smoother and more elastic.
  • Helps stimulate lymphatic circulation and reduce local swelling in the treated area.
  • Minimally invasive, non-surgical alternative to facial liposuction with relatively short downtime.

Indications

  • Reduction of localised facial fat in the lower face.
  • Double chin (submental fat) reduction.
  • Jawline contouring and V-line definition.
  • Cheek and "hamster cheek" slimming.
  • Neckline contour refinement.
  • Adjunct treatment in patients seeking non-surgical facial slimming in areas resistant to diet and exercise.

Composition

  • Phosphatidylcholine (PPC)
  • Sodium deoxycholate
  • Aesculus hippocastanum (horse chestnut) extract
  • Juglans regia seed extract
  • Fumaria officinalis extract
  • Anemone pulsatilla (Pulsatilla vulgaris) extract
  • Tyrosine
  • Thiamine
  • Manganese gluconate
  • Magnesium ascorbyl phosphate
  • Ascorbic acid
  • Niacinamide
  • Riboflavin
  • Pyridoxine
  • Conjugated linoleic acid
  • L-carnitine
  • Thermus thermophilus ferment/extract
  • Citric acid
  • Fumaric acid
  • 2-oxoglutaric acid
  • Malic acid
  • Succinic acid
  • Sodium oxaloacetate
  • Sodium pyruvate
  • Coenzyme A
  • Cysteine
  • Hyaluronate
  • Additional vitamins, amino acids and plant extracts as per full manufacturer INCI listing

Formulation

  • Injectable lipolytic solution for facial use.
  • Multi-ingredient formula combining PPC and sodium deoxycholate with plant extracts, vitamins, amino acids and enzymes.
  • Designed for subcutaneous injection into localised facial fat deposits.
  • Fat-dissolving solution with secondary skin-tightening and hydrating effects.
  • Manufactured in the Republic of Korea.

Packaging

  • Box containing 5 vials x 10 mL (standard pack).
  • Individual 10 mL vials also supplied by some distributors.
  • Sterile, single-use glass vials intended for professional injection only.
  • Primary packaging and labelling in accordance with Korean medical-aesthetic regulations.

Usage

  • For subcutaneous injection by suitably trained and licensed medical or aesthetic professionals only.
  • Indicated for injection into facial fat compartments such as jawline, chin and cheeks; may also be used in other small localised fat areas according to protocol.
  • Typical technique: inject approximately 0.1–0.2 cc per point at about 5 mm depth with injection points spaced around 1 cm apart, adjusting to anatomy and clinical judgement.
  • Number of sessions: commonly 2–4 treatment sessions are recommended for optimal results, based on the amount and distribution of fat.
  • Session interval: protocols vary; some distributors recommend short intervals (e.g. around 3 days), while manufacturer-level guidance describes multiple sessions spaced several weeks apart—practitioners should follow the latest manufacturer instructions and local clinical guidelines.
  • Monitor the patient during and after injection for pain, blanching, disproportionate swelling or other signs of vascular or nerve compromise.
  • Provide standard post-treatment advice, including avoidance of heat, strenuous exercise and massage on the treated area for a short period as per local protocol.
  • Always follow the instructions for use provided with the product and adhere to local regulations and scope of practice.

Contraindications

  • Known hypersensitivity or allergy to phosphatidylcholine, sodium deoxycholate, plant extracts, vitamins, amino acids, hyaluronate or any other component of the formulation.
  • Pregnancy or breastfeeding.
  • Active skin infection, inflammation, dermatitis or open wounds in or near the intended injection site.
  • Severe systemic illness or uncontrolled chronic disease without specialist assessment.
  • Significant liver, kidney or immune system disorders unless carefully evaluated and cleared by a physician.
  • Current severe bleeding disorders or use of strong anticoagulant/antiplatelet therapy without appropriate risk assessment.
  • History of severe allergic reactions or anaphylaxis to injectable products.
  • Unrealistic expectations or inability to comply with recommended aftercare.

Adverse Effects

  • Common transient reactions: local swelling, redness, bruising, warmth and tenderness at the injection site.
  • Temporary induration, nodules or lumpiness in the treated area as fat breaks down.
  • Mild itching or discomfort.
  • Short-term sensitivity or tightness in the lower face or neck region.
  • Less common: prolonged swelling, uneven contouring or asymmetry possibly requiring further management.
  • Rare but serious: infection, allergic reaction, prolonged pain, nerve irritation or damage, and significant inflammatory responses that require medical attention.

Storage Conditions

  • Store in accordance with the storage instructions on the original packaging and vial labels.
  • Keep in a cool, dry place away from direct sunlight and sources of heat.
  • Do not freeze.
  • Keep vials in their original box until use to maintain protection and traceability.
  • Do not use after the expiry date printed on the packaging.
  • Discard any vial with compromised integrity or visible defects in solution.

Duration

Initial visible improvements are usually reported within 2\u20134 weeks after the first session, with full results developing over approximately 6\u20138 weeks as dissolved fat is cleared. Destroyed fat cells in treated areas are considered long-lasting or permanent, provided body weight and lifestyle are maintained, although new fat accumulation remains possible.

Onset

Early contouring changes typically become noticeable within 2\u20134 weeks after treatment as lipolysis progresses and swelling subsides.

Browse more Fat Dissolver

Top Treatments

Top Cities in the UK